Abstract
BackgroundDeveloping novel strategies to overcome the immunosuppressive tumor microenvironment is a critically important area of cancer therapy research. Here, we assess the therapeutic potential of CD244 (2B4/signaling lymphocyte activation molecule...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have